A Study Evaluating The Safety, Efficacy and Pharmacokinetics Of Ipatasertib In Combination With Atezolizumab And Docetaxel In Metastatic Castration-Resistant Prostate Cancer (mCRPC).
Clinical trial NCT04404140 · TERMINATED
Trial details
- NCT number
- NCT04404140
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-09
- Primary completion
- 2022-10-14
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.